Reported Mar 27, 2019 · Terminated
Docusate Sodium, 100mg softgels, packaged in 10 x 10 unit dose blister cards, For institutional use only, Mfg by:…
Rx Pak Division of McKesson Corporation
Moderate riskThis product could cause temporary or reversible health problems — stop using it.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: Rx Pak Division of McKesson Corporation · 4971 Southridge Blvd Ste 111-115 · Memphis, TN · 38141-8300
Is this the product you have?
- Docusate Sodium, 100mg softgels, packaged in 10 x 10 unit dose blister cards, For institutional use only
- Mfg byAenova Holding GmBh, Miami, Fl 33186, NDC 63739-0478-10
- Lot codes and dates
Lot # 0119397Exp 02/2020
- Amount recalled
- 29,622 Blister Cards
Why it was recalled
Labeling: Label mix-up: Secondary carton may be labeled as Gabapentin 300mg instead of Docusate Sodium 100mg softgel caps.
This product could cause temporary or reversible health problems — stop using it.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Rx Pak Division recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.